iPSC-Derived Cardiomyocyte Cell Line from China
Induced pluripotent stem cell (iPSC)-derived cardiomyocytes grown in specialized media for cardiac repair therapies and drug toxicity testing. These cells are classified under tariff item 3002.59.00 as modified cell cultures for therapeutic uses.
Duty Rate — China → Canada
0%
Import Tips
• Provide evidence of the cells' modification and therapeutic application to support classification
• Check if the product requires a Health Canada license for clinical use
• Ensure proper documentation of the cell line's derivation and culture conditions